![Spevigo-Home-banner-background](/mea/ae/sites/default/files/2024-04/Interior_Pages_Hero_No_Rainbow_1.jpg)
54.3% of patients achieved complete pustular clearance* at Week 11,2
References
-
SPEVIGO® Summary of Product Characteristics. Boehringer Ingelheim Pharmaceuticals, Inc; 2022.
-
Bachelez H, Choon SE, Marrakchi S, et al; for the Effisayil 1 Trial Investigators. Trial of spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385(26):2431-2440. doi:10.1056/NEJMoa2111563
-
Strober B, Kotowsky N, Medeiros R, et al. Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of Corrona registry dermatologists. Dermatol Ther (Heidelb). 2021;11(2):529-541. doi:10.1007/s13555-021-00493-0
-
Data on File. Boehringer Ingelheim Pharmaceuticals, Inc.
-
Bachelez H, Barker J, Ghoreschi K, et al. Efficacy of spesolimab for the rapid control of generalized pustular psoriasis flares: results from the placebo-controlled Effisayil™ 1 study. Oral presentation at: European Academy of Dermatology and Venereology 30th Congress; September 29-October 2, 2021; Virtual. Abstract #345. Accessed September 30, 2022. https://www.globalmedcomms.com/immunology/EADV2021/Bachelez_oral/oral-presentation
-
Rentz AM, Skalicky AM, Dirk Esser D, et al. Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis. J Dermatolog Treat. 2020;31(5):460-469. doi:10.1080/09546634.2019.1709612
-
Gould D, Kelly D, Goldstone L, Gammon J. Examining the validity of pressure ulcer risk assessment scales: developing and using illustrated patient simulations to collect the data. J Clin Nurs. 2001;10(5):697-706. doi:10.1046/j.1365-2702.2001.00525.x
-
Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15(9):907-919. doi:10.1080/1744666X.2019.1648209
-
Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T. Diagnosis and screening of patients with generalized pustular psoriasis. Psoriasis (Auckl). 2019;9:37-42. doi:10.2147/PTT.S181808